LINC02718: A Long Intergenic Non-Protein Coding RNA (G105376592)

Target Name: LINC02718

NCBI ID: G105376592

LINC02718

Other Name(s): Long intergenic non-protein coding RNA 2718 | long intergenic non-protein coding RNA 2718

LINC02718: A Long Intergenic Non-Protein Coding RNA

LINC02718 is a long non-coding RNA (lncRNA) that has been identified in various organisms, including humans. It is characterized by its unique structure, which consists of multiple exons derived from different genic regions. LINC02718 is of interest as a potential drug target or biomarker due to its unique expression patterns and potential involvement in various cellular processes.

Structure and Expression

LINC02718 is a 21.9 kilobase (kb) RNA molecule. It is composed of 10 exons, which are derived from different genic regions. The exons range from 35 to 88 nucleotides in length. LINC02718 is expressed in various tissues and cells of the human body, including the brain, heart, and gastrointestinal tract.

One of the most striking features of LINC02718 is its unique structure. Unlike most lncRNAs, which have a single exon derived from a specific genic region, LINC02718 has multiple exons derived from different genic regions. This phenomenon is known as exonic enrichment. The multiple exons in LINC02718 may contribute to its unique expression patterns and potential functions.

Function and Potential Therapeutic Applications

LINC02718 is involved in various cellular processes that are crucial for human health and development. One of the most promising functions of LINC02718 is its potential as a drug target. LINC02718 has been shown to play a role in various signaling pathways, including cell adhesion, migration, and transcriptional regulation.

LINC02718 has also been shown to be involved in the regulation of ion channels, which are critical for the proper functioning of various cellular processes. The unique structure of LINC02718 and its multiple exons may make it an attractive target for small molecules that can modulate ion channels and disrupt disruptive signaling pathways.

In addition to its potential as a drug target, LINC02718 may also be a valuable biomarker for various diseases. The unique expression patterns of LINC02718 in different tissues and cells make it an attractive candidate for diagnostic tests. For example, LINC02718 has been shown to be expressed in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that LINC02718 may be a useful biomarker for cancer diagnosis and treatment.

Conclusion

LINC02718 is a long non-coding RNA that has unique structure and expression patterns. Its multiple exons derived from different genic regions and its involvement in various cellular processes make it a potential drug target and biomarker. Further research is needed to fully understand the unique functions of LINC02718 and its potential as a therapeutic agent.

Protein Name: Long Intergenic Non-protein Coding RNA 2718

The "LINC02718 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02718 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets